{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:31Z","timestamp":1792788571986,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FWO-Vlaanderen","award":["G. 0063.09N"],"award-info":[{"award-number":["G. 0063.09N"]}]},{"name":"European Commission FP7 NEWTBVAC project","award":["241745"],"award-info":[{"award-number":["241745"]}],"id":[{"id":"https:\/\/ror.org\/00k4n6c32","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31003A_135705"],"award-info":[{"award-number":["31003A_135705"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.034","type":"journal-article","created":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T11:32:06Z","timestamp":1356435126000},"page":"1057-1064","source":"Crossref","is-referenced-by-count":22,"title":["Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Ying","family":"Waeckerle-Men","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bruffaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Jurion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"K\u00fcndig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.12.034_bib0005","series-title":"Global tuberculosis control 2010","author":"WHO","year":"2010"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0020","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.01999-06","article-title":"Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination","volume":"75","author":"Lin","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0025","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20091473","article-title":"Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway","volume":"208","author":"Potian","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0030","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.4049\/jimmunol.0801694","article-title":"Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection","volume":"182","author":"Ryan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0035","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348:17\u201324.","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0045","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0264-410X(99)00540-X","article-title":"The immunogenicity of single and combination DNA vaccines against tuberculosis","volume":"18","author":"Morris","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0070","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1472-9792(12)70005-7","article-title":"Tuberculosis vaccines: a strategic blueprint for the next decade","volume":"92","author":"Brennan","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0075","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/emmm.201000125","article-title":"Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis","volume":"3","author":"Festjens","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0095","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant Mycobacterium bovis BCG","volume":"27","author":"Bastos","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0100","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/CVI.00015-11","article-title":"Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens","volume":"18","author":"Johansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/eji.200425599","article-title":"Direct intralymphatic injection of peptide vaccines enhances immunogenicity","volume":"35","author":"Johansen","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0120","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1172\/JCI35288","article-title":"Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice","volume":"119","author":"Korf","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2567.2006.02373.x","article-title":"Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3","volume":"118","author":"Romano","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0130","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.vaccine.2011.01.042","article-title":"Bacillus Calmette-Guerin vaccination using a microneedle patch","volume":"29","author":"Hiraishi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","article-title":"Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells","volume":"27","author":"Badell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1670","article-title":"Dendritic-cell trafficking to lymph nodes through lymphatic vessels","volume":"5","author":"Randolph","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri706","article-title":"A role for antigen in the maintenance of immunological memory","volume":"2","author":"Gray","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni951","article-title":"T cell receptor signaling required for synapse maintenance and full effector potential","volume":"4","author":"Huppa","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tube.2004.09.011","article-title":"Control of human host immunity to mycobacteria","volume":"85","author":"Ottenhoff","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0160","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0165","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.4049\/jimmunol.177.8.5647","article-title":"Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response","volume":"177","author":"Murray","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0170","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1128\/IAI.71.8.4297-4303.2003","article-title":"Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo","volume":"71","author":"Villarreal-Ramos","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/tropej\/fmp018","article-title":"Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children","volume":"55","author":"Bannister","year":"2009","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2012.12.034_bib0180","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201818X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201818X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:57:40Z","timestamp":1539971860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201818X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X1201818X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}